Investigating the effect of Gliclazide-MR on glycaemic control in type 2 diabetic patients
Phase 3
Recruiting
- Conditions
- Type 2 diabetes.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20230910059395N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Type 2 diabetes patients with HbA1C above 10%
Age over 30 years
Exclusion Criteria
Patients with kidney and liver failure
Heart failure
Stroke
Pregnancy
Previous receipt of gliclazide and insulin
Gastric problems
Consumption of sulfonylureas
Urine ketone positivity while having symptoms of polyuria
Diabetic ketoacidosis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1C. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: High Performance Liquid Chromatography(HPLC).;Fasting blood sugar (FBS). Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: High Performance Liquid Chromatography (HPLC).;Two-hour blood sugar (BS 2hpp). Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: High Performance Liquid Chromatography (HPLC).
- Secondary Outcome Measures
Name Time Method Excessive drinking and excessive urination. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Interview.;Weight. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Weight scale.